End-of-day quote
Shenzhen S.E.
03:30:00 30/04/2024 am IST
|
5-day change
|
1st Jan Change
|
8.62
CNY
|
+0.70%
|
|
+5.77%
|
-20.26%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,999
|
1,662
|
1,577
|
2,430
|
3,310
|
2,401
|
Enterprise Value (EV)
1 |
1,848
|
1,705
|
1,737
|
2,613
|
3,436
|
2,406
|
P/E ratio
|
54.7
x
|
125
x
|
-95.6
x
|
-42.7
x
|
-32.3
x
|
-133
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.91
x
|
2.87
x
|
2.95
x
|
4.94
x
|
7.97
x
|
6.98
x
|
EV / Revenue
|
1.77
x
|
2.94
x
|
3.25
x
|
5.32
x
|
8.28
x
|
7
x
|
EV / EBITDA
|
20.4
x
|
19.8
x
|
52.7
x
|
-50.4
x
|
-49.1
x
|
-81.6
x
|
EV / FCF
|
-12.8
x
|
-12.6
x
|
-21.3
x
|
32.6
x
|
19.1
x
|
15.6
x
|
FCF Yield
|
-7.82%
|
-7.95%
|
-4.68%
|
3.06%
|
5.23%
|
6.39%
|
Price to Book
|
5.49
x
|
4.4
x
|
4.37
x
|
8
x
|
16.4
x
|
13.1
x
|
Nbr of stocks (in thousands)
|
2,22,148
|
2,22,148
|
2,22,148
|
2,22,148
|
2,22,148
|
2,22,148
|
Reference price
2 |
9.000
|
7.480
|
7.100
|
10.94
|
14.90
|
10.81
|
Announcement Date
|
16/04/19
|
26/04/20
|
23/04/21
|
28/04/22
|
20/03/24
|
20/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,046
|
579.4
|
535.2
|
491.6
|
415.1
|
343.9
|
EBITDA
1 |
90.71
|
86.22
|
32.95
|
-51.89
|
-70
|
-29.47
|
EBIT
1 |
6.08
|
55.67
|
-10.41
|
-98.82
|
-159.3
|
-49.72
|
Operating Margin
|
0.58%
|
9.61%
|
-1.94%
|
-20.1%
|
-38.39%
|
-14.46%
|
Earnings before Tax (EBT)
1 |
67.74
|
47.15
|
-25.26
|
-115.2
|
-165.3
|
-41.89
|
Net income
1 |
36.51
|
13.33
|
-16.52
|
-56.96
|
-102.4
|
-18.11
|
Net margin
|
3.49%
|
2.3%
|
-3.09%
|
-11.59%
|
-24.68%
|
-5.27%
|
EPS
2 |
0.1644
|
0.0600
|
-0.0743
|
-0.2564
|
-0.4611
|
-0.0815
|
Free Cash Flow
1 |
-144.5
|
-135.5
|
-81.37
|
80.05
|
179.8
|
153.8
|
FCF margin
|
-13.81%
|
-23.39%
|
-15.2%
|
16.28%
|
43.31%
|
44.72%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
16/04/19
|
26/04/20
|
23/04/21
|
28/04/22
|
20/03/24
|
20/03/24
|
Fiscal Period: December |
2022 Q1
|
---|
Net sales
|
-
|
EBITDA
|
-
|
EBIT
|
-
|
Operating Margin
|
-
|
Earnings before Tax (EBT)
|
-
|
Net income
1 |
-14.37
|
Net margin
|
-
|
EPS
2 |
-0.0647
|
Dividend per Share
|
-
|
Announcement Date
|
28/04/22
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
43.6
|
160
|
183
|
126
|
4.31
|
Net Cash position
1 |
151
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
0.5062
x
|
4.842
x
|
-3.531
x
|
-1.804
x
|
-0.1461
x
|
Free Cash Flow
1 |
-144
|
-136
|
-81.4
|
80.1
|
180
|
154
|
ROE (net income / shareholders' equity)
|
11%
|
6.48%
|
-4.41%
|
-17.7%
|
-44.3%
|
-13.3%
|
ROA (Net income/ Total Assets)
|
0.29%
|
3.79%
|
-0.63%
|
-5.91%
|
-10.8%
|
-3.74%
|
Assets
1 |
12,416
|
351.4
|
2,609
|
964.2
|
945.8
|
484.5
|
Book Value Per Share
2 |
1.640
|
1.700
|
1.620
|
1.370
|
0.9100
|
0.8200
|
Cash Flow per Share
2 |
1.070
|
0.4800
|
0.2500
|
0.1300
|
0.0700
|
0.3500
|
Capex
1 |
118
|
146
|
61
|
17.5
|
14.5
|
147
|
Capex / Sales
|
11.32%
|
25.13%
|
11.4%
|
3.56%
|
3.5%
|
42.83%
|
Announcement Date
|
16/04/19
|
26/04/20
|
23/04/21
|
28/04/22
|
20/03/24
|
20/03/24
|
|
1st Jan change
|
Capi.
|
---|
| -20.26% | 265M | | +2.56% | 102B | | -1.20% | 66.01B | | +47.62% | 41.76B | | +15.99% | 38.66B | | +4.25% | 32.28B | | +8.78% | 19.57B | | +12.32% | 16.77B | | +17.69% | 15.08B | | +8.31% | 14.83B |
Other Commodity Chemicals
|